2022 was a complicated year. Global challenges like the Ukraine war and the continued impact of Covid-19 have been felt across the world. And yet it was also a year of incredible innovation in drug discovery, with the potential of new biotechnology beginning to be revealed. Our top 10 most… Read More
Following the news that the number of clinical trial recruiting sites in Ukraine has dropped by half since the Russian invasion, DDW’s Diana Spencer examines clinical trial data from analytics company Phesi and speaks to Dr Olena Karpenko, Clinical Research Director at Medical Center Ok!Clinic+ to understand the impact… Read More
New global data analysis from Phesi shows the extent of the impact from the war in Ukraine on clinical development. Phesi analysed pivotal trials sponsored by pharmaceutical companies that represent the most critical global clinical development activities. The findings The findings show that… Read More
James Tyrrell, Chair, Global Health, APCO Worldwide, assesses the pharmaceutical industry’s response to the Russian invasion of Ukraine and its ramifications on the sector. With no quick end to Russia’s invasion of Ukraine, life sciences companies are increasingly being challenged to… Read More
